In a latest transaction, the Chief Expertise Officer of Vicarious Surgical Inc. (NYSE:RBOT), Sammy Khalifa, offered shares of the corporate’s inventory, producing over $3,500 in proceeds. The transaction happened on August 20, 2024, and was reported in a Type 4 submitting with the Securities and Change Fee.
Khalifa disposed of 559 shares of Class A Widespread Inventory at a weighted common value starting from $6.20 to $6.51 per share. The overall worth of the shares offered amounted to roughly $3,515, primarily based on the common sale value of $6.2895 per share. The sale was performed to cowl tax withholding obligations associated to the vesting of restricted inventory items granted to Khalifa on Might 19, 2022.
Following the sale, Khalifa’s possession within the firm stands at 39,001 shares of Vicarious Surgical Inc. The corporate, which is classed below the orthopedic, prosthetic, and surgical home equipment and provides trade, is included in Delaware with a fiscal yr ending on December 31.
Buyers and stakeholders can request detailed details about the variety of shares offered at every separate value from Khalifa, Vicarious Surgical Inc., or the SEC if wanted.
The transaction was signed off by Erin Checka, Legal professional-in-Reality, on August 21, 2024. Khalifa’s latest sale is a part of the routine monetary disclosures required by firm insiders and supplies transparency into the buying and selling actions of Vicarious Surgical’s executives.
In different latest information, Vicarious Surgical Inc. has skilled a number of noteworthy developments. The corporate reported its Q2 monetary outcomes, disclosing an adjusted earnings per share (EPS) of -$2.86, barely under the consensus estimate of -$2.72. Working bills elevated by 17% year-over-year to $17.7 million, primarily as a consequence of investments in analysis and growth and normal and administrative bills. Regardless of these elevated prices, Vicarious Surgical confirmed it’s on observe with the event of its V1.0 system, projected for completion by Fall 2024.
TD Cowen raised its value goal for Vicarious Surgical to $10.00 from $1.50, sustaining a Purchase ranking on the inventory. This adjustment was made in gentle of the corporate’s progress within the growth of its robotic system. In distinction, Piper Sandler lowered its value goal for the corporate to $12 from $30, whereas sustaining a impartial stance. This resolution adopted the announcement of the corporate’s Q2 outcomes.
Vicarious Surgical is advancing its V1.0 surgical system integration and medical trial plans, together with partnerships with hospital methods like LSU Well being New Orleans. These latest developments are a part of the corporate’s broader technique to transition its know-how from growth to sensible software in surgical procedures. The corporate anticipates preliminary medical affected person testing in 2025.
InvestingPro Insights
In gentle of the latest inventory sale by Vicarious Surgical Inc.’s (NYSE:RBOT) Chief Expertise Officer, Sammy Khalifa, traders could also be within the firm’s present monetary well being and market efficiency. In response to InvestingPro knowledge, Vicarious Surgical Inc. has a market capitalization of $38.04 million and is experiencing vital volatility in its inventory value, with a 16.88% return over the past week however substantial declines over longer intervals, together with a 76.83% drop over the previous yr.
InvestingPro Suggestions counsel that whereas the corporate holds more money than debt on its stability sheet, which is a optimistic signal of liquidity, it’s shortly burning via money and has weak gross revenue margins. Analysts don’t anticipate the corporate will likely be worthwhile this yr, and the valuation implies a poor free money circulate yield. These elements may very well be contributing to the inventory’s poor efficiency over the past month and three months, with value decreases of 19.75% and 40.93%, respectively.
For traders searching for a deeper evaluation of Vicarious Surgical Inc., there are extra InvestingPro Suggestions obtainable at InvestingPro Vicarious Surgical Inc., which supply insights into the corporate’s financials, market place, and potential future efficiency.
This text was generated with the help of AI and reviewed by an editor. For extra data see our T&C.
